D Botta-Fridlund Selected Research

Transjugular Intrahepatic Portasystemic Shunt

6/2016

The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Botta-Fridlund Research Topics

Disease

3	Ischemia 12/2009 - 11/2000
2	Fibrosis (Cirrhosis) 01/2018 - 01/2001
2	Hemorrhage 06/2016 - 01/2001
2	Hepatitis C 05/2003 - 06/2000
1	Chronic Renal Insufficiency 01/2018
1	End Stage Liver Disease 06/2016
1	Ascites 06/2016
1	Hepatic Encephalopathy 06/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2016
1	Varicose Veins (Varicose Vein) 06/2016
1	Pathologic Constriction (Stenosis) 12/2009

Drug/Important Bio-Agent (IBA)

2	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 05/2003
1	CreatinineIBA 01/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018
1	InterferonsIBA 05/2003
1	Actins (F Actin)IBA 08/2001
1	vapreotideIBA 01/2001
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2001
1	GlycogenIBA 11/2000
1	DNA (Deoxyribonucleic Acid)IBA 06/2000

Therapy/Procedure

1	Surgical Portasystemic Shunt (Portosystemic Shunt) 06/2016
1	Transjugular Intrahepatic Portasystemic Shunt 06/2016
1	Liver Transplantation 12/2009
1	Retreatment 05/2003
1	Lasers (Laser) 08/2001